Protective effect of ginsenoside Rh2 against Toxoplasma gondii infection-induced neuronal injury through binding TgCDPK1 and NLRP3 to inhibit microglial NLRP3 inflammasome signaling pathway
- 5 September 2022
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 112, 109176
Abstract
No abstract availableKeywords
Funding Information
- Higher Education Discipline Innovation Project (D18012)
- Shinshu University
- National Natural Science Foundation of China (81660344)
- National Natural Science Foundation of China (81960375)
This publication has 65 references indexed in Scilit:
- Epidemiology of and Diagnostic Strategies for ToxoplasmosisClinical Microbiology Reviews, 2012
- Mechanisms Underlying Inflammation in NeurodegenerationCell, 2010
- The InflammasomesCell, 2010
- Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 ExpressionThe Journal of Immunology, 2009
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- Progress in understanding of ginsenoside biosynthesisPlant Biology, 2008
- Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanismProgress in Neurobiology, 2005
- ROLES OF IFN-γ ON STAGE CONVERSION OF AN OBLIGATE INTRACELLULAR PROTOZOAN PARASITE, Toxoplasma GondiiInternational Reviews of Immunology, 2002
- Immortalization of murine microglial cells by a v-raf / v-myc carrying retrovirusJournal of Neuroimmunology, 1990